Back to results
US 2017/0304303 A1Published application
Novel Pyrimidinyl-DiazoSpiro Compounds
AssigneeConvergence Pharmaceuticals Limited
InventorsGerard M.P. Giblin, David T. MacPherson, David R. Witty, Steven J. Stanway
Life of this patent
Estimating the term…
Abstract
The invention relates to spiro deriviatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.
Claims11
1-10. (canceled)
A compound which is (5S)-7-Methyl-2-[4-methyl-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-yl]-1,7-diazaspiro[4.4]non-1-en-6-one (D9).
Dependencies are inferred from the claim text.